Evaluation of the Effectiveness and Safety of Electroacupuncture in Patients with Intractable Neuropathic Pain

Lee, S.; Lee, C.S.; Kim, J.; Lee, S.H.; Seo, Hye-Jin; Moon, Jee Youn

doi:10.1016/j.jams.2018.08.108

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At the second visit, the symptoms of discomfort and heat sensation were relieved. Lee et al [13] revealed that Scolopendrae Corpus pharmacopuncture had analgesic effects for neuropathic pain that could not be controlled by conventional painkillers such as NSAIDs and opioids. Other testing indicated that it was effective against inflammation and entrapment neuropathy [14].…”

Section: Discussionmentioning

confidence: 99%

Case Study of a Patient with Trigger Finger after Conducting Pharmacopuncture according to the Progress

Huh

Lee

et al. 2023

J Pharmacopuncture

View full text Add to dashboard Cite

Our study purpose was to report the clinical application of five different pharmacopunctures (Sweet BV, Scolopendrae Corpus, Chukyu, Cervi Parvum Cornu, and Hominis Placenta) for trigger finger. A patient was admitted to Ba-reun-mom S Korean Medicine Clinic and diagnosed with trigger finger. Because the effects of each pharmacopuncture have been confirmed in various acute to chronic cases, we treated a patient diagnosed with trigger finger using pharmacopunctures Sweet BV and Scolopendrae Corpus at the acute phase, Chukyu pharmacopuncture at the acute to chronic phase, and pharmacopunctures Cervi Parvum Cornu and Hominis Placenta at the chronic phase. This case was measured and assessed by Quinnell's classification of triggering and visual analogue scale (VAS) scores. After treatment, the patient's fifth finger pain and function were improved. The VAS score decreased from 5 to 0. The Quinnell's classification of triggering score decreased from 2 to 0. This case indicated that a patient with trigger finger could be treated by five pharmacopuncture treatments according to the treatment regimen and disease progress.

show abstract

Section: Discussionmentioning

confidence: 99%